The DEA Is Placing Kratom And Mitragynine On Schedule I

With the federal intent to place the herb and its bioactive constituents on Schedule I, the DEA is ignoring the increasing scientific literature on a potential beneficial medical use of the plant. Schedule I classification, used for drugs with no known medical use and high abuse potential, will certainly make subsequent research on the plant more difficult.